Kymera Therapeutics Inc (KYMR)
48.07
+3.09
(+6.87%)
USD |
NASDAQ |
Nov 25, 15:29
Kymera Therapeutics Total Liabilities (Quarterly): 141.91M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 141.91M |
| June 30, 2024 | 141.10M |
| March 31, 2024 | 157.05M |
| December 31, 2023 | 180.79M |
| September 30, 2023 | 156.84M |
| June 30, 2023 | 146.52M |
| March 31, 2023 | 151.90M |
| December 31, 2022 | 112.98M |
| September 30, 2022 | 125.59M |
| June 30, 2022 | 125.47M |
| Date | Value |
|---|---|
| March 31, 2022 | 134.34M |
| December 31, 2021 | 146.27M |
| September 30, 2021 | 159.32M |
| June 30, 2021 | 176.28M |
| March 31, 2021 | 189.30M |
| December 31, 2020 | 203.29M |
| September 30, 2020 | 212.68M |
| June 30, 2020 | 77.07M |
| December 31, 2019 | 191.11M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
77.07M
Minimum
Jun 2020
212.68M
Maximum
Sep 2020
154.20M
Average
151.90M
Median
Mar 2023
Total Liabilities (Quarterly) Benchmarks
| Amgen Inc | 83.36B |
| Voyager Therapeutics Inc | 95.73M |
| Denali Therapeutics Inc | 135.52M |
| Vir Biotechnology Inc | 257.63M |
| CEL-SCI Corp | 15.60M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.035B |
| Shareholders Equity (Quarterly) | 892.93M |
| Current Ratio | 8.548 |